Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

NINDS Neuroscience Funding Announcements



National Gene Vector Laboratories

Funding Contact: NINDS Funding Coordinator
Funding Categories: Translational Research

Brief Description:

The National Gene Vector Laboratories (NGVL) were established in 1995 to produce clinical grade vectors for human gene transfer protocols. The purpose of this Request for Applications (RFA) is to continue the support of the NGVL to produce and distribute such vectors and to perform related toxicology studies for Phase I and II human clinical gene transfer protocols. For purposes of this solicitation, the term “vector” is used in the broadest sense to refer to any vehicle designed to deliver genetic material into human somatic cells for therapeutic purposes.



NIH Guide: RFA-RR-01-001
Release Date: 2000-12-01
Expiration Date: 2001-02-23